Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 5 | Fluids and Barriers of the CNS

Fig. 5

From: Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding

Fig. 5

Levels of sAPPα in the brain following ADAM10 modulation in a mouse model of AD. PSAPP mice (35 weeks of age) were treated in an acute 5-day treatment paradigm with ADAM10 inhibitor GI254023X (200 mg/kg) or vehicle (DMSO) which were administered via intraperitoneal injection. One hour after the final treatment, the brains were collected and sAPPα in the whole brain homogenate was probed using an sAPPα ELISA. Values represent mean ± SEM (n = 8–9) and are expressed as the amount of sAPPα per mg total protein. Statistical significance determined by an unpaired t test

Back to article page